Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong ...

Cathay Pharma has emerged as a specialised logistics solution tailored to meet the rigorous demands of the healthcare and ...

Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...

BNP Secretary General Mirza Fakhrul Islam Alamgir has warned of a severe crisis in the pharmaceutical industry, alleging that ...

FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 12% growth forecast ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...